May 21, 2024, 12:00
Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center shared on X:
“A review in International Journal of Oncology discusses mechanisms of senescence‑associated drug resistance in lymphoma and highlights emerging strategies using senolytics, which are drugs designed to specifically target senescent cells.”
Read further.
Source: Michael Wang/X
cancer
Cancer Treatment Strategies
Cellular Therapy
drug resistance mechanisms
International Journal of Oncology
lymphoma
MD Anderson Cancer Center
medical review
Michael Wang
Myeloma
OncoDaily
Oncology
oncology research
senescence-associated drug resistance
senescent cells
senolytics
Stem Cell Transplantation